0001179110-12-007021.txt : 20120420
0001179110-12-007021.hdr.sgml : 20120420
20120420163047
ACCESSION NUMBER: 0001179110-12-007021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120420
FILED AS OF DATE: 20120420
DATE AS OF CHANGE: 20120420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HRUSOVSKY E KEVIN
CENTRAL INDEX KEY: 0001252546
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34105
FILM NUMBER: 12771135
MAIL ADDRESS:
STREET 1: 68 ELM STREET
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SERACARE LIFE SCIENCES INC
CENTRAL INDEX KEY: 0001156295
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 330056054
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 37 BIRCH STREET
CITY: MILFORD
STATE: MA
ZIP: 01757
BUSINESS PHONE: 5082446400
MAIL ADDRESS:
STREET 1: 37 BIRCH STREET
CITY: MILFORD
STATE: MA
ZIP: 01757
4
1
edgar.xml
FORM 4 -
X0305
4
2012-04-20
0
0001156295
SERACARE LIFE SCIENCES INC
SRLS
0001252546
HRUSOVSKY E KEVIN
C/O SERACARE LIFE SCIENCES, INC.
37 BIRCH STREET
MILFORD
MA
01757
1
0
0
0
Common Stock
2012-04-20
4
D
0
2739
D
0
D
Stock Option (Right to Buy)
2.73
2012-04-20
4
D
0
3750
D
2016-11-16
Common Stock
3750
0
D
Stock Option (Right to Buy)
2.73
2012-04-20
4
D
0
11250
D
2016-11-16
Common Stock
11250
0
D
Stock Option (Right to Buy)
3.86
2012-04-20
4
D
0
7890
D
2015-11-17
Common Stock
7890
0
D
Pursuant to the Agreement and Plan of Merger dated as of February 12, 2012, as amended by Amendment No. 1 to Agreement and Plan of Merger dated as of February 27, 2012, among SeraCare Life Sciences, Inc., Project Plasma Holdings Corporation and Project Plasma Merger Corp. (the "Merger Agreement"), each share of SeraCare Life Sciences, Inc.'s common stock was exchanged for $4.00 in cash, without interest and less any applicable withholding taxes.
Pursuant to its terms, the stock option accelerated and became fully vested as of the closing of the merger.
This stock option is fully vested.
Pursuant to the Merger Agreement, each stock option was cancelled in the merger in exchange for the right to receive an amount in cash, without interest, equal to the product of the number of shares issuable upon the exercise of such stock option and $4.00 minus the exercise price of such stock option, less any applicable withholding taxes.
/s/ Gregory A. Gould, Attorney-in-fact
2012-04-20